Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients

被引:11
作者
Brocks, DR
Freed, MI
Martin, DE
Sellers, TS
Mehdi, N
Citerone, DR
Boppana, V
Levitt, B
Davies, BE
Nemunaitis, J
Jorkasky, DK
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT DRUG METAB,KING OF PRUSSIA,PA 19406
[2] SMITHKLINE BEECHAM PHARMACEUT,DEPT PHARMACOKINET,KING OF PRUSSIA,PA 19406
[3] SMITHKLINE BEECHAM PHARMACEUT,DEPT TOXICOL,KING OF PRUSSIA,PA 19406
[4] SMITHKLINE BEECHAM PHARMACEUT,DEPT CLIN PHARMACOL,PHILADELPHIA,PA 19406
[5] HAFSLUND NYCOMBED PHARMA AG,LINZ,AUSTRIA
关键词
allometric scaling; peptide; pharmacokinetics; hematology; infection;
D O I
10.1023/A:1016020221300
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To study the pharmacokinetics of SK&F 107647, a novel hematoregulatory agent, in rats, dogs, and patients with non-lymphoid solid tumor malignancy. Methods. Sprague Dawley rats and beagle dogs (n = 6 each; 3 M, 3 Fl were given 25 mg/kg of SK&F 107467 as an iv bolus injection, and patients (n = 6; 4 M, 2 Fl received 100 ng/kg as a 2 hour iv infusion. Plasma samples were assayed for drug using either HPLC (rat and dog) or RIA (human). Results. In each species the plasma clearance (CL) of SK&F 107647 was low in relation to hepatic blood flow, and the volume of distribution (Vd(ss)) was reflective of distribution to extracellular body water. The plasma CL in humans was near that of average glomerular filtration rate. Using allometric equations for interspecies scaling (Y = a . W-b), body-weight normalized human pharmacokinetic data were reasonably predicted using either the body weight normalized rat or the dog data. The allometric exponents (b) for CL, Vd(ss), and T-1/2 Of SK&F 107647 were 0.63, 0.94, and 0.29, respectively. Conclusions. Use of a limited pool of available animal data allowed for reasonable predictions of human pharmacokinetics of SK&F 107647.
引用
收藏
页码:794 / 797
页数:4
相关论文
共 14 条
[1]  
ALLEN GD, 1990, BIOPHARM DRUG DISPOS, V10, P477
[2]   DETERMINATION OF A NOVEL HEMATOREGULATORY PEPTIDE IN DOG PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND AN AMINE-SELECTIVE O-PHTHALDIALDEHYDETHIOL POSTCOLUMN REACTION WITH FLUORESCENCE DETECTION [J].
BOPPANA, VK ;
MILLERSTEIN, C .
JOURNAL OF CHROMATOGRAPHY A, 1994, 676 (01) :161-167
[3]  
CHAPPELL WR, 1991, ADV DRUG RES, V20, P1
[4]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[5]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[6]  
ELDER CA, 1995, DRUG METAB DISPOS, V23, P776
[7]   RENAL UPTAKE AND DEGRADATION OF TRAPPED-LABEL CALCITONIN [J].
HYSING, J ;
GORDELADZE, JO ;
CHRISTENSEN, G ;
TOLLESHAUG, H .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (08) :1119-1126
[8]  
LIN JH, 1995, DRUG METAB DISPOS, V23, P1008
[9]   RENAL FILTRATION, TRANSPORT, AND METABOLISM OF LOW-MOLECULAR-WEIGHT PROTEINS - REVIEW [J].
MAACK, T ;
JOHNSON, V ;
KAU, ST ;
FIGUEIREDO, J ;
SIGULEM, D .
KIDNEY INTERNATIONAL, 1979, 16 (03) :251-270
[10]  
Maack T, 1992, KIDNEY PHYSL PATHOPH, P3005